Started Semaglutide Together and Your Partner Lost Faster?

You started the same week, on the same dose, eating largely the same food in the same house. Four months in, they are visibly ahead and you are doing the mental arithmetic every time you see them.

It is a miserable position, partly because there is no one to be annoyed at. Here is what actually accounts for most of these gaps, and what is worth raising with your provider.

Most of the difference is not about effort

A 2026 review of what predicts response to semaglutide gathered this up, and the pattern is more structural than people expect.

Sex is the single biggest predictor in most datasets. Women lose more than men on average, by a meaningful margin. If you are the man in this comparison, that alone may account for most of what you are seeing.

Type 2 diabetes reduces the response substantially. People with type 2 diabetes lose noticeably less on the same drug at the same dose than people without it. This is one of the most consistent findings in the literature and it is not something either of you is doing.

Maintenance dose matters. Higher maintenance doses produce more weight loss on average. If one of you has moved up and the other has held, that is a real difference even if you started together.

Age and starting BMI do surprisingly little across most populations.

Adding intensive behavioral therapy did not produce greater long-term weight loss in the studies the review drew on, which is counterintuitive and worth sitting with if you have concluded that they are simply trying harder than you.

The review also noted that genetic differences in the GLP-1 receptor have only modest predictive value, and that some emerging work on obesity phenotypes looks promising but is not yet something to plan around.

The comparison is measuring the wrong thing

Two people rarely start from the same place even when they start on the same day.

A larger person losing the same percentage of their body weight loses more pounds. On a bathroom scale that looks like a different drug working. Percentage is the comparison that means anything, and almost nobody makes it.

Water weight also lands differently in the first weeks and muddies any early comparison. And weight moves in steps rather than smoothly, so two people on identical trajectories can look wildly different for a month at a time purely because their plateaus are out of phase.

Consider this scenario: a couple starts together. He is heavier and has no diabetes diagnosis. She has type 2 diabetes. At five months he is down noticeably more in pounds and she has concluded her medication is not working. Converted to percentages and adjusted for the diabetes effect, both are responding about as the literature would predict. Nothing is wrong. They have been comparing the wrong number for five months.

Our guide on tracking your progress covers what is actually worth recording, and it is mostly not the daily number.

The things that are worth checking

A few differences are real and fixable.

Are you actually on the same dose and schedule? People assume this and are sometimes wrong. Escalation timing often diverges when one person tolerates increases better than the other.

Are you on the same medication? Semaglutide and tirzepatide are different drugs with different average results and different side effect profiles. Our guide on how tirzepatide and semaglutide side effects compare covers the differences that matter day to day.

Did one of you start at a different point in the escalation? Our guide on the semaglutide starting dose covers how the early steps are meant to work, and a slower ramp for tolerance reasons shifts the whole curve.

Is anything else moving? Strength training changes body composition in ways the scale actively hides. Someone whose clothes fit differently while the number holds is not failing.

When slow is worth raising

Separate from the comparison, there is a real clinical question: is your own response what it should be?

The rough marker providers use is whether meaningful weight loss has happened by around the three to four month mark at a full therapeutic dose. Not compared to your partner. Compared to nothing.

If you are well past that, at a proper dose, with little movement, that is a legitimate conversation. Options exist, including dose adjustment, switching medications, and checking whether something else is contributing. It is a reason to ask rather than a reason to worry, and it is a conversation worth having on its own terms rather than as a response to someone else’s results.

Living in the house

The practical problem is that you cannot stop seeing their progress.

A few things help. Stop weighing on the same day, or in front of each other. Agree that results are not a shared conversation topic unless someone raises it. If they are the sort to announce numbers, ask them not to, and be specific rather than hoping they notice.

And it is worth saying the thing directly, once: that you are pleased for them and also finding it hard, and that both are true. Partners usually have no idea this is happening, and the silence tends to curdle into something that looks like resentment of them rather than frustration at the situation.

Talk to your provider if

You have had little response after three to four months at a full dose, your dose has not been reviewed in some time, side effects are limiting your ability to move up, or you are not sure whether what you are seeing is normal for your circumstances. That last one is worth a call by itself. A provider can tell you in one conversation whether your trajectory is unremarkable, and that is usually the answer.

The short version

Sex, diabetes status, and maintenance dose account for most of these gaps, and none of them are about effort. Compare percentages rather than pounds if you are going to compare at all. Check that you are genuinely on the same drug, dose, and schedule before concluding anything. And judge your own response against the three to four month marker rather than against the person across the table.

If you want a provider who will review your dose rather than wait for you to ask, TrimRx includes ongoing provider access alongside treatment.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.